Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

Presentation TCT 2017

WaveCrest: Device Description, Data, and Future Directions

Presenter: Mark Reisman, Josep Rodés-Cabau, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

Anticipating CoAPT: Two Year Roll-in Results and RCT Progress

Presenter: James B. Hermiller Jr., Ralph Stephan von Bardeleben, Gregg W. Stone

October 30, 2017

Presentation TCT 2017

Keynote Lecture. European Commission: Evolving Impact of Device Regulation in Europe

Presenter: Gregg W. Stone, Bram D. Zuckerman, Alan G. Fraser

October 30, 2017

Presentation TCT 2017

Keynote Lecture - FDA/CDRH: Evolving Impact of Device Regulation in the US

Presenter: Gregg W. Stone, Bram D. Zuckerman, William H. Maisel

October 30, 2017

Presentation TCT 2017

The Impact of Regulation on Forty Years of PCI and 15 years of TAVR: Industry Perspectives

Presenter: Gregg W. Stone, Bram D. Zuckerman, Richard E. Kuntz

October 30, 2017

Presentation TCT 2017

The Impact of Regulation on Forty Years of PCI and 15 years of TAVR: Physician-Scientist Perspectives

Presenter: Gregg W. Stone, Bram D. Zuckerman

October 30, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

Presentation LAA 2017

Early and Late Results With the Wavecrest LAA Occluder (and Future Studies)

Presenter: Gregg W. Stone

July 22, 2017

News Conference News TVT 2017

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

Shelley Wood

June 15, 2017

News Industry News

4C Medical's Mitral Regurgitation Therapy to be Featured in 2017 TVT Innovation Forum

June 08, 2017

Podcast

Episode 13: Left Main Revascularization, Bifurcation Stenting, and LAA Closure

May 17, 2017

News Conference News ACC 2017

MitraClip Commercial Experience at 1 Year Sheds Light on Progress and Lingering Concerns

L.A. McKeown

March 27, 2017

News Conference News ACC 2017

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Michael O'Riordan

March 19, 2017

News Conference News ACC 2017

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

Todd Neale

March 17, 2017

News Daily News

Edward ‘Ted’ Diethrich, Founder of the Arizona Heart Institute, Dies at 81

L.A. McKeown

March 01, 2017

Advertisement

WaveCrest: Device Description, Data, and Future Directions

Anticipating CoAPT: Two Year Roll-in Results and RCT Progress

Keynote Lecture. European Commission: Evolving Impact of Device Regulation in Europe

Keynote Lecture - FDA/CDRH: Evolving Impact of Device Regulation in the US

The Impact of Regulation on Forty Years of PCI and 15 years of TAVR: Industry Perspectives

The Impact of Regulation on Forty Years of PCI and 15 years of TAVR: Physician-Scientist Perspectives

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Early and Late Results With the Wavecrest LAA Occluder (and Future Studies)

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

4C Medical's Mitral Regurgitation Therapy to be Featured in 2017 TVT Innovation Forum

Episode 13: Left Main Revascularization, Bifurcation Stenting, and LAA Closure

MitraClip Commercial Experience at 1 Year Sheds Light on Progress and Lingering Concerns

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

Edward ‘Ted’ Diethrich, Founder of the Arizona Heart Institute, Dies at 81

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content